I'm surprised there has been no comment yet about the quarterly update. OK, so it was fairly brief, but there were a couple of good positives in it.
For a start, the company expects to have sufficient funding to meet operating costs until August next year - not taking into account any royalties received in the mean time. So capital raisings are off the agenda for a fair while at least.
I also like the comments regarding other companies that have finished their own laboratory testing and are now discussing commercial aspects. This I take to mean contract negotiations. Surely, if things have progressed as positively as the announcement implies, this means further production/supply agreements will not be too far away.
Here's hoping anyway.
ADO Price at posting:
4.7¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)